Symbols / VIVS Stock $1.30 +0.78% VivoSim Labs, Inc.
VIVS (Stock) Chart
Stock Fundamentals
|
|
|
|
|
|
About
Official websiteVivoSim Labs, Inc., a pharmaceutical and biotechnology services company, provides testing of drugs and drug candidates in three-dimensional (3D) human tissue models of liver and intestine. It offers partners liver and intestinal toxicology insights through its new approach methodologies (NAM) models; and bespoke services in the areas of investigational toxicology, mechanism of drug action elucidation, and other applications of complex human tissue models. The company also provides liver toxicology predictive screening and research services, as well as works on predicting and studying the intestinal side effect profiles of drugs that are therapeutic candidates of pharmaceutical and biotech companies at various stages of drug development; and uses its proprietary technologies to build functional 3D human tissues that mimic key aspects of native human tissue composition, architecture, function, and disease. In addition, it offers 3D human tissue platform that develops novel human normal and disease models using high throughput systems, bioprinted, and flow/stretch capable 3D systems. The company was formerly known as Organovo Holdings, Inc. and changed its name to VivoSim Labs, Inc. in April 2025. VivoSim Labs, Inc. was incorporated in 2007 and is headquartered in San Diego, California.
Ratings
Current target
$1.30
Low
—
High
—
Mean
—
- Can AI replace animal tests? VivoSim cites 96% diarrhea accuracy - Stock Titan ue, 28 Apr 2026 07
- Why Is VIVS Stock Up 79% Today? - Stocktwits hu, 05 Mar 2026 08
- VIVS Stock Chart | VIVOSIM LABS INC (NASDAQ:VIVS) - ChartMill hu, 14 May 2026 07
- $VIVS stock is up 71% today. Here's what we see in our data. - Quiver Quantitative Fri, 30 Jan 2026 08
- VivoSim Labs Stock Soars After Major Distribution Deals in Asia - timothysykes.com Sat, 31 Jan 2026 08
- Lobbying Update: $10,000 of VIVOSIM LABS INC. lobbying was just disclosed - Quiver Quantitative Fri, 08 May 2026 07
- VivoSim Labs Leaps 82% Amid Strategic Partnerships in Asia - StocksToTrade Sun, 01 Feb 2026 08
- VIVS Forecast — Price Prediction for 2026. Should I Buy VIVS? - Intellectia AI Fri, 23 Jan 2026 00
- symbol__ Stock Quote Price and Forecast - CNN Fri, 25 Apr 2025 16
- VivoSim Labs prices $4 million public offering at $1.14/share - Investing.com Wed, 01 Apr 2026 07
- VivoSim Labs (VIVS) director awarded 15,000 restricted stock units - Stock Titan hu, 29 Jan 2026 08
- Which stocks are moving before the opening bell on Wednesday? - ChartMill Wed, 01 Apr 2026 07
- VIVS Stock Price and Chart — NASDAQ:VIVS - TradingView hu, 24 Apr 2025 12
- VivoSim Labs Expands Amid Global Market Challenges - StocksToTrade Fri, 30 Jan 2026 08
- [EFFECT] VivoSim Labs, INC. SEC Filing - Stock Titan ue, 31 Mar 2026 07
Insider Transactions
Financials
Statement View
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Revenue |
|
0.14
+32.11%
|
0.11
-70.54%
|
0.37
-75.33%
|
1.50
|
| Operating Revenue |
|
0.14
+32.11%
|
0.11
-70.54%
|
0.37
-75.33%
|
1.50
|
| Cost Of Revenue |
|
0.01
|
0.00
|
—
|
—
|
| Reconciled Cost Of Revenue |
|
0.01
|
0.00
|
—
|
—
|
| Gross Profit |
|
0.14
+27.52%
|
0.11
|
—
|
—
|
| Operating Expense |
|
12.76
-16.06%
|
15.20
-16.05%
|
18.10
+39.46%
|
12.98
|
| Research And Development |
|
5.03
-8.60%
|
5.50
-38.12%
|
8.88
+167.62%
|
3.32
|
| Selling General And Administration |
|
7.69
-20.25%
|
9.64
+6.12%
|
9.09
-5.64%
|
9.63
|
| General And Administrative Expense |
|
7.69
-20.25%
|
9.64
+6.12%
|
9.09
-5.64%
|
9.63
|
| Salaries And Wages |
|
0.45
-67.45%
|
1.37
-28.05%
|
1.90
+3.65%
|
1.84
|
| Other Gand A |
|
7.25
-12.44%
|
8.27
+15.17%
|
7.18
-7.83%
|
7.79
|
| Total Expenses |
|
12.76
-16.03%
|
15.20
-16.05%
|
18.10
+39.46%
|
12.98
|
| Operating Income |
|
-12.62
+16.37%
|
-15.09
+14.92%
|
-17.73
-54.46%
|
-11.48
|
| Total Operating Income As Reported |
|
-12.62
+16.37%
|
-15.09
+14.92%
|
-17.73
-54.46%
|
-11.48
|
| EBITDA |
|
-2.21
+84.64%
|
-14.39
+17.48%
|
-17.44
-53.81%
|
-11.34
|
| Normalized EBITDA |
|
-12.21
+15.21%
|
-14.40
+17.51%
|
-17.46
-53.99%
|
-11.34
|
| Reconciled Depreciation |
|
0.27
-5.00%
|
0.28
-4.44%
|
0.29
+106.34%
|
0.14
|
| EBIT |
|
-2.48
+83.12%
|
-14.67
+17.27%
|
-17.73
-54.46%
|
-11.48
|
| Total Unusual Items |
|
10.00
+83233.33%
|
0.01
-40.00%
|
0.02
|
0.00
|
| Total Unusual Items Excluding Goodwill |
|
10.00
+83233.33%
|
0.01
-40.00%
|
0.02
|
0.00
|
| Special Income Charges |
|
10.00
|
0.00
+100.00%
|
-0.01
|
0.00
|
| Net Income |
|
-2.49
+83.04%
|
-14.67
+15.00%
|
-17.26
-50.76%
|
-11.45
|
| Pretax Income |
|
-2.49
+83.05%
|
-14.67
+15.00%
|
-17.26
-50.77%
|
-11.45
|
| Net Non Operating Interest Income Expense |
|
0.13
-67.90%
|
0.41
-10.79%
|
0.45
+5575.00%
|
0.01
|
| Interest Expense Non Operating |
|
0.01
|
0.00
|
—
|
—
|
| Net Interest Income |
|
0.13
-67.90%
|
0.41
-10.79%
|
0.45
+5575.00%
|
0.01
|
| Interest Expense |
|
0.01
|
0.00
|
—
|
—
|
| Interest Income Non Operating |
|
0.14
-65.43%
|
0.41
-10.79%
|
0.45
+5575.00%
|
0.01
|
| Interest Income |
|
0.14
-65.43%
|
0.41
-10.79%
|
0.45
+5575.00%
|
0.01
|
| Other Income Expense |
|
10.00
+83233.33%
|
0.01
-40.00%
|
0.02
-20.00%
|
0.03
|
| Other Non Operating Income Expenses |
|
—
|
—
|
—
|
0.03
|
| Gain On Sale Of Security |
|
—
|
0.01
-58.62%
|
0.03
|
—
|
| Tax Provision |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Tax Rate For Calcs |
|
0.00
|
0.00
|
0.00
-100.00%
|
0.00
|
| Tax Effect Of Unusual Items |
|
2.10
|
0.00
|
0.00
|
0.00
|
| Net Income Including Noncontrolling Interests |
|
-2.49
+83.04%
|
-14.67
+15.00%
|
-17.26
-50.76%
|
-11.45
|
| Net Income From Continuing Operation Net Minority Interest |
|
-2.49
+83.04%
|
-14.67
+15.00%
|
-17.26
-50.76%
|
-11.45
|
| Net Income From Continuing And Discontinued Operation |
|
-2.49
+83.04%
|
-14.67
+15.00%
|
-17.26
-50.76%
|
-11.45
|
| Net Income Continuous Operations |
|
-2.49
+83.04%
|
-14.67
+15.00%
|
-17.26
-50.76%
|
-11.45
|
| Normalized Income |
|
-10.39
+29.25%
|
-14.68
+15.02%
|
-17.28
-50.93%
|
-11.45
|
| Net Income Common Stockholders |
|
-2.49
+83.04%
|
-14.67
+15.00%
|
-17.26
-50.76%
|
-11.45
|
| Diluted EPS |
|
-1.70
+91.17%
|
-19.25
+18.98%
|
-23.76
-50.00%
|
-15.84
|
| Basic EPS |
|
-1.70
+91.17%
|
-19.25
+18.98%
|
-23.76
-50.00%
|
-15.84
|
| Basic Average Shares |
|
1.46
+92.06%
|
0.76
+4.96%
|
0.73
+0.11%
|
0.73
|
| Diluted Average Shares |
|
1.46
+92.06%
|
0.76
+4.96%
|
0.73
+0.11%
|
0.73
|
| Diluted NI Availto Com Stockholders |
|
-2.49
+83.04%
|
-14.67
+15.00%
|
-17.26
-50.76%
|
-11.45
|
| Depreciation Amortization Depletion Income Statement |
|
0.04
-26.42%
|
0.05
-58.59%
|
0.13
+357.14%
|
0.03
|
| Depreciation And Amortization In Income Statement |
|
0.04
-26.42%
|
0.05
-58.59%
|
0.13
+357.14%
|
0.03
|
| Gain On Sale Of PPE |
|
10.00
|
0.00
+100.00%
|
-0.01
|
0.00
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Total Assets |
|
14.65
+130.74%
|
6.35
-68.74%
|
20.31
-38.99%
|
33.30
|
| Current Assets |
|
12.13
+208.21%
|
3.94
-76.91%
|
17.05
-42.27%
|
29.53
|
| Cash Cash Equivalents And Short Term Investments |
|
11.31
+289.93%
|
2.90
-81.88%
|
16.01
-44.18%
|
28.68
|
| Cash And Cash Equivalents |
|
11.31
+289.93%
|
2.90
-81.04%
|
15.30
-46.64%
|
28.68
|
| Other Short Term Investments |
|
—
|
0.00
-100.00%
|
0.71
|
0.00
|
| Receivables |
|
0.03
-9.09%
|
0.03
-78.29%
|
0.15
|
0.00
|
| Accounts Receivable |
|
0.03
-9.09%
|
0.03
-78.29%
|
0.15
|
0.00
|
| Inventory |
|
0.00
-100.00%
|
0.30
|
0.00
|
—
|
| Finished Goods |
|
0.00
-100.00%
|
0.30
|
0.00
|
—
|
| Prepaid Assets |
|
0.78
+10.84%
|
0.70
-14.51%
|
0.82
-4.43%
|
0.86
|
| Other Current Assets |
|
0.01
+200.00%
|
0.00
-94.20%
|
0.07
-91.96%
|
0.86
|
| Total Non Current Assets |
|
2.52
+4.39%
|
2.41
-26.09%
|
3.27
-13.23%
|
3.76
|
| Net PPE |
|
1.29
-34.65%
|
1.97
-24.51%
|
2.61
-7.39%
|
2.81
|
| Gross PPE |
|
2.81
-12.99%
|
3.23
-16.92%
|
3.88
-0.08%
|
3.89
|
| Accumulated Depreciation |
|
-1.52
-20.91%
|
-1.26
+1.41%
|
-1.28
-19.14%
|
-1.07
|
| Properties |
|
0.00
|
0.00
|
0.00
|
0.00
|
| Buildings And Improvements |
|
0.87
-33.26%
|
1.30
-23.81%
|
1.71
-20.81%
|
2.15
|
| Machinery Furniture Equipment |
|
0.31
+0.00%
|
0.31
-48.59%
|
0.60
+7.30%
|
0.56
|
| Other Properties |
|
1.63
+0.80%
|
1.62
+2.67%
|
1.57
+34.50%
|
1.17
|
| Non Current Prepaid Assets |
|
—
|
—
|
—
|
0.81
|
| Other Non Current Assets |
|
1.23
+177.08%
|
0.45
-32.37%
|
0.66
-30.59%
|
0.95
|
| Total Liabilities Net Minority Interest |
|
4.16
+51.31%
|
2.75
-44.86%
|
4.98
+61.45%
|
3.09
|
| Current Liabilities |
|
3.74
+100.91%
|
1.86
-49.33%
|
3.67
+165.44%
|
1.38
|
| Payables And Accrued Expenses |
|
2.22
+171.15%
|
0.82
-68.17%
|
2.57
+446.81%
|
0.47
|
| Payables |
|
1.64
+162.20%
|
0.63
+89.43%
|
0.33
-20.24%
|
0.41
|
| Accounts Payable |
|
1.64
+162.20%
|
0.63
+89.43%
|
0.33
-20.24%
|
0.41
|
| Current Accrued Expenses |
|
0.57
+200.52%
|
0.19
-91.47%
|
2.24
+3970.91%
|
0.06
|
| Pensionand Other Post Retirement Benefit Plans Current |
|
0.65
+21.64%
|
0.54
-11.99%
|
0.61
+40.32%
|
0.43
|
| Current Debt And Capital Lease Obligation |
|
0.52
+2.96%
|
0.51
+2.85%
|
0.49
+2.71%
|
0.48
|
| Current Capital Lease Obligation |
|
0.52
+2.96%
|
0.51
+2.85%
|
0.49
+2.71%
|
0.48
|
| Other Current Liabilities |
|
0.35
|
—
|
—
|
—
|
| Total Non Current Liabilities Net Minority Interest |
|
0.42
-52.59%
|
0.89
-32.37%
|
1.31
-22.95%
|
1.70
|
| Long Term Debt And Capital Lease Obligation |
|
0.42
-52.59%
|
0.89
-32.37%
|
1.31
-22.95%
|
1.70
|
| Long Term Capital Lease Obligation |
|
0.42
-52.59%
|
0.89
-32.37%
|
1.31
-22.95%
|
1.70
|
| Stockholders Equity |
|
10.49
+191.36%
|
3.60
-76.51%
|
15.33
-49.26%
|
30.21
|
| Common Stock Equity |
|
10.49
+191.36%
|
3.60
-76.51%
|
15.33
-49.26%
|
30.21
|
| Capital Stock |
|
0.00
+100.00%
|
0.00
-88.89%
|
0.01
+0.00%
|
0.01
|
| Common Stock |
|
0.00
+100.00%
|
0.00
-88.89%
|
0.01
+0.00%
|
0.01
|
| Share Issued |
|
1.90
+126.01%
|
0.84
+15.61%
|
0.73
+0.07%
|
0.73
|
| Ordinary Shares Number |
|
1.90
+126.01%
|
0.84
+15.61%
|
0.73
+0.07%
|
0.73
|
| Treasury Shares Number |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Additional Paid In Capital |
|
352.65
+2.73%
|
343.27
+0.87%
|
340.32
+0.70%
|
337.94
|
| Retained Earnings |
|
-342.16
-0.73%
|
-339.67
-4.51%
|
-325.00
-5.61%
|
-307.74
|
| Gains Losses Not Affecting Retained Earnings |
|
—
|
0.00
-100.00%
|
0.00
|
0.00
|
| Treasury Stock |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Other Equity Adjustments |
|
—
|
—
|
0.00
|
—
|
| Total Equity Gross Minority Interest |
|
10.49
+191.36%
|
3.60
-76.51%
|
15.33
-49.26%
|
30.21
|
| Total Capitalization |
|
10.49
+191.36%
|
3.60
-76.51%
|
15.33
-49.26%
|
30.21
|
| Working Capital |
|
8.39
+304.34%
|
2.08
-84.48%
|
13.38
-52.48%
|
28.15
|
| Invested Capital |
|
10.49
+191.36%
|
3.60
-76.51%
|
15.33
-49.26%
|
30.21
|
| Total Debt |
|
0.94
-32.42%
|
1.39
-22.77%
|
1.80
-17.32%
|
2.18
|
| Capital Lease Obligations |
|
0.94
-32.42%
|
1.39
-22.77%
|
1.80
-17.32%
|
2.18
|
| Net Tangible Assets |
|
10.49
+191.36%
|
3.60
-76.51%
|
15.33
-49.26%
|
30.21
|
| Tangible Book Value |
|
10.49
+191.36%
|
3.60
-76.51%
|
15.33
-49.26%
|
30.21
|
| Line Item | Trend | 2025-03-31 | 2024-03-31 | 2023-03-31 | 2022-03-31 |
|---|---|---|---|---|---|
| Operating Cash Flow |
|
-9.46
+35.43%
|
-14.65
-18.09%
|
-12.41
-46.79%
|
-8.45
|
| Cash Flow From Continuing Operating Activities |
|
-9.46
+35.43%
|
-14.65
-18.09%
|
-12.41
-46.79%
|
-8.45
|
| Net Income From Continuing Operations |
|
-2.49
+83.04%
|
-14.67
+15.00%
|
-17.26
-50.76%
|
-11.45
|
| Depreciation Amortization Depletion |
|
0.27
-5.00%
|
0.28
-4.44%
|
0.29
+106.34%
|
0.14
|
| Depreciation And Amortization |
|
0.27
-5.00%
|
0.28
-4.44%
|
0.29
+106.34%
|
0.14
|
| Other Non Cash Items |
|
0.43
+6.40%
|
0.41
|
—
|
—
|
| Stock Based Compensation |
|
0.53
-64.72%
|
1.51
-36.56%
|
2.38
+5.36%
|
2.26
|
| Asset Impairment Charge |
|
0.80
|
0.00
|
—
|
—
|
| Operating Gains Losses |
|
-10.00
-83233.33%
|
-0.01
+40.00%
|
-0.02
|
—
|
| Gain Loss On Sale Of PPE |
|
—
|
0.00
-100.00%
|
0.01
|
0.00
|
| Change In Working Capital |
|
1.04
+151.29%
|
-2.02
-187.68%
|
2.31
+286.26%
|
0.60
|
| Change In Receivables |
|
0.00
-97.48%
|
0.12
+178.29%
|
-0.15
|
0.00
|
| Changes In Account Receivables |
|
0.00
-97.48%
|
0.12
+178.29%
|
-0.15
|
0.00
|
| Change In Inventory |
|
-0.50
-68.69%
|
-0.30
|
0.00
|
—
|
| Change In Prepaid Assets |
|
0.25
-35.46%
|
0.39
+121.47%
|
0.18
-53.91%
|
0.38
|
| Change In Payables And Accrued Expense |
|
1.73
+195.01%
|
-1.82
-182.54%
|
2.21
+1108.20%
|
0.18
|
| Change In Accrued Expense |
|
0.72
+133.80%
|
-2.12
-189.91%
|
2.36
+4714.29%
|
0.05
|
| Change In Payable |
|
1.02
+243.58%
|
0.30
+300.00%
|
-0.15
-210.45%
|
0.13
|
| Change In Account Payable |
|
1.02
+243.58%
|
0.30
+300.00%
|
-0.15
-210.45%
|
0.13
|
| Change In Other Working Capital |
|
—
|
-0.01
-107.14%
|
0.07
+133.33%
|
0.03
|
| Change In Other Current Liabilities |
|
-0.45
-9.98%
|
-0.41
|
—
|
—
|
| Investing Cash Flow |
|
9.03
+1006.00%
|
0.82
+184.47%
|
-0.97
-136.19%
|
-0.41
|
| Cash Flow From Continuing Investing Activities |
|
9.03
+1006.00%
|
0.82
+184.47%
|
-0.97
-136.19%
|
-0.41
|
| Net PPE Purchase And Sale |
|
8.99
+21497.62%
|
-0.04
+89.39%
|
-0.40
+3.18%
|
-0.41
|
| Purchase Of PPE |
|
-0.01
+69.05%
|
-0.04
+89.39%
|
-0.40
+3.18%
|
-0.41
|
| Sale Of PPE |
|
9.00
|
0.00
|
—
|
0.00
|
| Capital Expenditure |
|
-0.01
+69.05%
|
-0.04
+89.39%
|
-0.40
+3.18%
|
-0.41
|
| Net Investment Purchase And Sale |
|
0.04
-95.57%
|
0.86
+250.53%
|
-0.57
|
0.00
|
| Purchase Of Investment |
|
-2.96
+72.73%
|
-10.86
+0.86%
|
-10.95
|
0.00
|
| Sale Of Investment |
|
3.00
-74.40%
|
11.72
+12.85%
|
10.38
|
0.00
|
| Financing Cash Flow |
|
8.85
+515.66%
|
1.44
|
0.00
-100.00%
|
0.20
|
| Cash Flow From Continuing Financing Activities |
|
8.85
+515.66%
|
1.44
|
0.00
-100.00%
|
0.20
|
| Net Common Stock Issuance |
|
8.85
+515.66%
|
1.44
|
0.00
-100.00%
|
0.25
|
| Common Stock Payments |
|
—
|
—
|
—
|
0.00
|
| Repurchase Of Capital Stock |
|
—
|
—
|
—
|
0.00
|
| Proceeds From Stock Option Exercised |
|
—
|
—
|
—
|
0.00
|
| Net Other Financing Charges |
|
—
|
—
|
—
|
-0.05
|
| Changes In Cash |
|
8.41
+167.83%
|
-12.40
+7.28%
|
-13.37
-54.49%
|
-8.66
|
| Beginning Cash Position |
|
3.04
-80.29%
|
15.44
-46.41%
|
28.82
-23.10%
|
37.48
|
| End Cash Position |
|
11.46
+276.31%
|
3.04
-80.29%
|
15.44
-46.41%
|
28.82
|
| Free Cash Flow |
|
-9.47
+35.53%
|
-14.70
-14.77%
|
-12.80
-44.48%
|
-8.86
|
| Interest Paid Supplemental Data |
|
0.01
|
0.00
|
—
|
—
|
| Income Tax Paid Supplemental Data |
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
+0.00%
|
0.00
|
| Amortization Of Securities |
|
-0.04
+73.24%
|
-0.14
-35.24%
|
-0.10
|
0.00
|
| Common Stock Issuance |
|
8.85
+515.66%
|
1.44
|
0.00
-100.00%
|
0.25
|
| Earnings Losses From Equity Investments |
|
0.00
+100.00%
|
-0.01
+58.62%
|
-0.03
|
0.00
|
| Issuance Of Capital Stock |
|
8.85
+515.66%
|
1.44
|
0.00
-100.00%
|
0.25
|
SEC Filings
Recent 10-K, 10-Q, 8-K, and Form 4 (insider) filings.
- 8-K2026-04-03 View
- 10-Q2026-02-11 View
- 42026-01-29 View
- 42026-01-29 View
- 42026-01-29 View
- 42026-01-29 View
- 42026-01-29 View
- 8-K2025-12-18 View
- 42025-11-26 View
- 42025-11-19 View
- 10-Q2025-11-06 View
- 42025-08-21 View
- 8-K2025-08-14 View
- 10-Q2025-08-12 View
- 10-K2025-06-05 View
- 8-K2025-05-06 View
- 8-K2025-04-24 View
- 8-K2025-04-23 View
- 8-K2025-04-02 View
- 8-K2025-03-27 View
Trades
| Date | User | Broker | Pattern | Type | Position Size | Entry Price | Trade P&L | Status |
|---|
Posts
| Published | Title | Author | Category |
|---|